Gastrointestinal dysmotility.
Division of Gastroenterology and Hepatology, Stanford University Hospital, Stanford, CA, USA.
Ashish
A
Nimgaonkar
Jung W
JW
Choi
Linda
L
Nguyen
George
G
Triadafilopoulos
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage; D001905:Botulinum Toxins / Q000008:administration & dosage*; D003679:Deglutition / Q000187:drug effects; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging / Q000379:methods*; D003938:Diagnostic Techniques, Digestive System; D019468:Disease Management; D004750:Enteral Nutrition / Q000379:methods; D004917:Erythromycin / Q000008:administration & dosage*; D015155:Esophageal Spasm, Diffuse / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017219:Gastric Outlet Obstruction / Q000175:diagnosis*; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D005769:Gastrointestinal Motility / Q000187:drug effects; D018589:Gastroparesis / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008297:Male; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D005765:Gastrointestinal Agents; D004917:Erythromycin; D001905:Botulinum Toxins